OnTrackCF: Engagement, Feasibility, and Acceptability Study

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Cystic Fibrosis (CF)Cystic Fibrosis - Complete
Interventions
BEHAVIORAL

OnTrackCF

OnTrackCF is a mHealth application co-developed with Upstream Dream. It is designed specifically to track and support adherence to CFTR modulator therapy. The app allows users to track their modulator intake and disease symptoms while supporting their adherence goals using Behavioral Change Techniques (BCTs) with empirical evidence of efficacy. The BCTs are administered primarily in the form of messages designed to deliver specific BCTs. The app sends up to 3 adherence support messages per day and provides detailed data to the user about their adherence levels, adherence goals, and disease symptoms. This process will continue until we reach an N=60 AWCF enrolled OR demonstrate that we have achieved 12 weeks of sustained user engagement with the app.

Trial Locations (3)

21218

Johns Hopkins University, Baltimore

35233

University of Alabama-Birmingham, Birmingham

02115

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

University of Alabama at Birmingham

OTHER

lead

Boston Children's Hospital

OTHER

NCT07031323 - OnTrackCF: Engagement, Feasibility, and Acceptability Study | Biotech Hunter | Biotech Hunter